Efficacy of Acthar gel and Tacrolimus in DNA-JB9 Positive Fibrillary Glomerulopathy

By afschroeder • September 23, 2025

Tumlin JA, Podoll A, Kopyt N, Rovin B, Lafayette R, Bomback A, Glassock R, Whitson J, Press A, Appel GB. Efficacy of Acthar gel and Tacrolimus in DNA-JB9 Positive Fibrillary Glomerulopathy. Kidney Int Rep. 2025 Jun 30;10(9):3128-3137. doi: 10.1016/j.ekir.2025.06.042. PMID: 40980649; PMCID: PMC12446950.

Tags: DNA-JB9, Emeritus, FACT trial, fibrillary glomerulopathy, Nephrology, Publications

Kassem Safa, MD Appointed Medical Director of the UCLA Kidney Transplant Program

The UCLA Department of Medicine has appointed Kassem Safa, MD, as medical director of the UCLA Kidney Transplant Program in the division of nephrology, effective[...]

A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA nephropathy

Laxamana TD, Fervenza FC, Glassock RJ, Zand L. A case of adrenal insufficiency after initiation of targeted-release budesonide formulation (Nefecon) in a patient with IgA[...]

Is Obinutuzumab the Answer to Primary Membranous Nephropathy Resistant to Rituximab?

Giri K, Glassock RJ, Fervenza FC. Is Obinutuzumab the Answer to Primary Membranous Nephropathy Resistant to Rituximab? Kidney Int Rep. 2026 Mar 4;11(4):106416. doi: 10.1016/j.ekir.2026.106416.[...]